These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 15656392

  • 1. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
    Fedorova TA, Il'ina IuV, Sotnikova TI, Rybakova MK.
    Klin Med (Mosk); 2004; 82(11):15-20. PubMed ID: 15656392
    [Abstract] [Full Text] [Related]

  • 2. [Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease].
    Fedorova TA, Il'ina IuV, Sotnikova TI, Rybakova MK, Loshchits NV.
    Ter Arkh; 2004; 76(3):62-8. PubMed ID: 15108463
    [Abstract] [Full Text] [Related]

  • 3. Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure.
    Fragasso G, Salerno A, Lattuada G, Cuko A, Calori G, Scollo A, Ragogna F, Arioli F, Bassanelli G, Spoladore R, Luzi L, Margonato A, Perseghin G.
    Heart; 2011 Sep; 97(18):1495-500. PubMed ID: 21700755
    [Abstract] [Full Text] [Related]

  • 4. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
    Di Napoli P, Di Giovanni P, Gaeta MA, Taccardi AA, Barsotti A.
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):585-9. PubMed ID: 18030070
    [Abstract] [Full Text] [Related]

  • 5. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
    Vitale C, Wajngaten M, Sposato B, Gebara O, Rossini P, Fini M, Volterrani M, Rosano GM.
    Eur Heart J; 2004 Oct; 25(20):1814-21. PubMed ID: 15474696
    [Abstract] [Full Text] [Related]

  • 6. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
    Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, Calori G, Alfieri O, Margonato A.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):992-8. PubMed ID: 16949492
    [Abstract] [Full Text] [Related]

  • 7. Trimetazidine shortens QTc interval in patients with ischemic heart failure.
    Zemljic G, Bunc M, Vrtovec B.
    J Cardiovasc Pharmacol Ther; 2010 Mar 05; 15(1):31-6. PubMed ID: 19966175
    [Abstract] [Full Text] [Related]

  • 8. [Effects of trimetazidine on serum oxygen free radicals in congestive heart failure].
    Ma QL, Xie Y, Zhang SD.
    Hunan Yi Ke Da Xue Xue Bao; 2002 Dec 28; 27(6):527-9. PubMed ID: 12658930
    [Abstract] [Full Text] [Related]

  • 9. [Clinicopathogenetic features of coronary heart disease combined with chronic obstructive pulmonary diseases and efficiency of therapy with trimetazidin].
    Kolomoets NM, Baksheev VI, Uvaĭsova KU.
    Klin Med (Mosk); 2008 Dec 28; 86(6):38-43. PubMed ID: 18720710
    [Abstract] [Full Text] [Related]

  • 10. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
    Marazzi G, Gebara O, Vitale C, Caminiti G, Wajngarten M, Volterrani M, Ramires JA, Rosano G, Fini M.
    Adv Ther; 2009 Apr 28; 26(4):455-61. PubMed ID: 19396409
    [Abstract] [Full Text] [Related]

  • 11. [Optimization of use of beta-adrenoblockers in the treatment of chronic heart failure in the outpatient setting].
    Zhubrina ES, Ovchinnikov AG, Seredenina EM, Patrusheva IF, Blankova ZN, Kuz'mina AE, Kheĭmets GI, Ageev FT.
    Ter Arkh; 2009 Apr 28; 81(11):35-40. PubMed ID: 20141011
    [Abstract] [Full Text] [Related]

  • 12. [Anti-ischemic effects of trimetazidine in patients with post-infarction heart failure].
    Tepliakov AT, Sankevich qV, Stepacheva TA, Garganeeva AA, Filippov EA, Pushnikova EIu, Kaliuzhin VV, Efimova I, Zavadovskiĭ KV.
    Klin Med (Mosk); 2004 Apr 28; 82(5):57-62. PubMed ID: 15230045
    [Abstract] [Full Text] [Related]

  • 13. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
    Fragasso G, Perseghin G, De Cobelli F, Esposito A, Palloshi A, Lattuada G, Scifo P, Calori G, Del Maschio A, Margonato A.
    Eur Heart J; 2006 Apr 28; 27(8):942-8. PubMed ID: 16510466
    [Abstract] [Full Text] [Related]

  • 14. Physical training in patients with chronic heart failure of ischemic origin: effect on exercise capacity and left ventricular remodeling.
    Klecha A, Kawecka-Jaszcz K, Bacior B, Kubinyi A, Pasowicz M, Klimeczek P, Banyś R.
    Eur J Cardiovasc Prev Rehabil; 2007 Feb 28; 14(1):85-91. PubMed ID: 17301632
    [Abstract] [Full Text] [Related]

  • 15. [The effects of trimetazidine on left ventricular function and physical exercise tolerance in patients with ischemic cardiomyopathy].
    Sisakian AS, Torgomian AL, Barkhudarian AL.
    Klin Med (Mosk); 2006 Feb 28; 84(10):55-8. PubMed ID: 17201276
    [Abstract] [Full Text] [Related]

  • 16. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).
    Böhm M, Maack C, Wehrlen-Grandjean M, Erdmann E.
    Z Kardiol; 2003 Aug 28; 92(8):668-76. PubMed ID: 12955414
    [Abstract] [Full Text] [Related]

  • 17. [Trimetazidine effects on postinfarction remodeling of the left ventricle].
    Kokov AN, Tarasov II, Barbarash LS.
    Ter Arkh; 2005 Aug 28; 77(8):10-4. PubMed ID: 16206598
    [Abstract] [Full Text] [Related]

  • 18. [Enhancement of antioxidant status of the elderly patients with ischemic heart disease in response to amino acid composition of MP-33 in combined therapy with trimetazidine].
    Kalinina EB, Komissarova IA, Zaslavskaia RM, Zhdanov IuA.
    Klin Med (Mosk); 2002 Aug 28; 80(5):50-3. PubMed ID: 12087889
    [Abstract] [Full Text] [Related]

  • 19. [Effect of combination therapy with preduktal and prestarium on the left ventricular function in the postinfarction period].
    Dzhindzholiia NR, Megreladze II.
    Georgian Med News; 2008 Feb 28; (155):20-3. PubMed ID: 18401050
    [Abstract] [Full Text] [Related]

  • 20. Beneficial electrophysiological effects of trimetazidine in patients with postischemic chronic heart failure.
    Cera M, Salerno A, Fragasso G, Montanaro C, Gardini C, Marinosci G, Arioli F, Spoladore R, Facchini A, Godino C, Margonato A.
    J Cardiovasc Pharmacol Ther; 2010 Mar 28; 15(1):24-30. PubMed ID: 20100903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.